 |
|
|
 |
|
|
 |
|
|
| Cortex Pharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of novel drugs called AMPAKINE molecules targeted towards the treatment of human central nervous system diseases. AMPAKINE molecules represent a new approach to treating psychiatric disorders, neurological diseases and brain mediated breathing disorders through their ability to increase communication between brain cells. |
|
|
|
|
|
|
